New York State Common Retirement Fund
FBLG icon

New York State Common Retirement Fund’s FibroBiologics FBLG Stock Holding History

New York State Common Retirement Fund’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-145
Closed -$2.61K – 3360
2025
Q1 		$2.61K Hold
145
– – ﹤0.01% 3149
2024
Q4 		$5.8K Hold
145
– – ﹤0.01% 3140
2024
Q3 		$8.96K Sell
145
-930
-87% -$61.8K ﹤0.01% 3117
2024
Q2 		$107K Buy
+1,075
New +$205K ﹤0.01% 2721

Other funds holding FBLG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund's FBLG Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of FibroBiologics (FBLG) in Q2 2025, closing a stake of 145 shares — an estimated $2.61K sold.

New York State Common Retirement Fund first reported a position in FBLG in Q2 2024 and held it in 4 quarters. The position peaked at $107K in Q2 2024. 57 funds tracked by Wall St. Rank hold FBLG as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining FibroBiologics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 145 FibroBiologics shares in Q2 2025, an estimated $2.61K.
  • New York State Common Retirement Fund first reported a position in FibroBiologics in Q2 2024 and held it in 4 quarters.
  • New York State Common Retirement Fund's FibroBiologics position peaked at $107K in Q2 2024.
  • 57 funds tracked by Wall St. Rank held FibroBiologics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.